Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A large outbreak of COVID-19 linked to an end of term trip to Menorca (Spain) by secondary school students in summer 2021.
Forcadell-Díez L, Rius C, Salobral R, Sánchez-Valdivia N, Mendioroz J, Godoy P, Badiella Jarque E, Ferrandiz-Mont D, Moreno Cervera D, Jordan Suriñach B, Vilalta-Carrera A, Guadalupe-Fernández V, Mateo Basilio J, Farràs Tapiol S, Pérez G. Forcadell-Díez L, et al. Among authors: mendioroz j. PLoS One. 2023 Feb 3;18(2):e0280614. doi: 10.1371/journal.pone.0280614. eCollection 2023. PLoS One. 2023. PMID: 36735702 Free PMC article.
Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain).
Coma E, Martinez-Marcos M, Hermosilla E, Mendioroz J, Reñé A, Fina F, Perramon-Malavez A, Prats C, Cereza G, Ciruela P, Pineda V, Antón A, Ricós-Furió G, Soriano-Arandes A, Cabezas C. Coma E, et al. Among authors: mendioroz j. Arch Dis Child. 2024 Aug 16;109(9):736-741. doi: 10.1136/archdischild-2024-327153. Arch Dis Child. 2024. PMID: 38857952 Free PMC article.
Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.
Fontán-Vela M, Hernando V, Olmedo C, Coma E, Martínez M, Moreno-Perez D, Lorusso N, Vázquez Torres M, Barbas Del Buey JF, Roig-Sena J, Pastor E, Galmés Truyols A, Artigues Serra F, Sancho Martínez RM, Latasa Zamalloa P, Pérez Martínez O, Vázquez Estepa A, García Rojas AJ, Barreno Estévez AI, Sánchez-Migallón Naranjo A, Pérez Martín JJ, Peces Jiménez P, Morales Romero R, Castilla J, García Cenoz M, Huerta Huerta M, Boone ALD, Macías Ortiz MJ, Álvarez Río V, Rodríguez Recio MJ, Merino Díaz M, Berradre Sáenz B, Villegas-Moreno MT, Limia A, Diaz A, Monge S; Spanish MPOX Vaccine Effectiveness Study Group. Fontán-Vela M, et al. Clin Infect Dis. 2024 Feb 17;78(2):476-483. doi: 10.1093/cid/ciad645. Clin Infect Dis. 2024. PMID: 37864849 Free PMC article.
Investigating epidemiological distribution (temporality and intensity) of respiratory pathogens following COVID-19 de-escalation process in Catalonia, September 2016-June 2021: Analysis of regional surveillance data.
Guadalupe-Fernández V, Martínez-Solanas E, Sabrià-Sunyé A, Ferrer-Mikoly C, Martínez-Mateo A, Ciruela-Navas P, Mendioroz J, Basile L; Epidemiological Surveillance Network of Catalonia. Guadalupe-Fernández V, et al. Among authors: mendioroz j. PLoS One. 2024 Feb 9;19(2):e0285892. doi: 10.1371/journal.pone.0285892. eCollection 2024. PLoS One. 2024. PMID: 38335176 Free PMC article.
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.
Laniece Delaunay C, Mazagatos C, Martínez-Baz I, Túri G, Goerlitz L, Domegan L, Meijer A, Rodrigues AP, Sève N, Ilic M, Latorre-Margalef N, Lazar M, Maurel M, Melo A, Andreu Ivorra B, Casado I, Horváth JK, Buda S, Bennett C, de Lange M, Guiomar R, Enouf V, Mlinaric I, Samuelsson Hagey T, Dinu S, Rumayor M, Castilla J, Oroszi B, Dürrwald R, O'Donnell J, Hooiveld M, Gomez V, Falchi A, Kurecic Filipovic S, Dillner L, Popescu R, Bacci S, Kaczmarek M, Kissling E; VEBIS Primary Care Vaccine Effectiveness Group. Laniece Delaunay C, et al. JAMA Netw Open. 2024 Jul 1;7(7):e2419258. doi: 10.1001/jamanetworkopen.2024.19258. JAMA Netw Open. 2024. PMID: 38949812 Free PMC article.
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain.
Mazagatos C, Mendioroz J, Rumayor MB, Gallardo García V, Álvarez Río V, Cebollada Gracia AD, Batalla Rebollo N, Barranco Boada MI, Pérez-Martínez O, Lameiras Azevedo AS, López González-Coviella N, Castrillejo D, Fernández Ibáñez A, Giménez Duran J, Ramírez Córcoles C, Ramos Marín V, Larrauri A, Monge S; SARI Sentinel Surveillance RSV Study Group. Mazagatos C, et al. Among authors: mendioroz j. Influenza Other Respir Viruses. 2024 May;18(5):e13294. doi: 10.1111/irv.13294. Influenza Other Respir Viruses. 2024. PMID: 38716791 Free PMC article.
Effectiveness of Nirsevimab Immunoprophylaxis Against Respiratory Syncytial Virus-related Outcomes in Hospital Care Settings: A Seasonal Cohort Study of Infants in Catalonia (Spain).
Perramon-Malavez A, Hermosilla E, Coma E, Fina F, Reñé A, Martínez-Marcos M, Mendioroz J, Prats C, Soriano-Arandes A, Cabezas C. Perramon-Malavez A, et al. Among authors: mendioroz j. Pediatr Infect Dis J. 2025 Jan 17. doi: 10.1097/INF.0000000000004672. Online ahead of print. Pediatr Infect Dis J. 2025. PMID: 39823640
Introduction of nirsevimab in Catalonia, Spain: description of the incidence of bronchiolitis and respiratory syncytial virus in the 2023/2024 season.
Perramon-Malavez A, de Rioja VL, Coma E, Hermosilla E, Fina F, Martínez-Marcos M, Mendioroz J, Cabezas C, Montañola-Sales C, Prats C, Soriano-Arandes A. Perramon-Malavez A, et al. Among authors: mendioroz j. Eur J Pediatr. 2024 Dec;183(12):5181-5189. doi: 10.1007/s00431-024-05779-x. Epub 2024 Sep 28. Eur J Pediatr. 2024. PMID: 39340677 Free PMC article.
39 results